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Abstract: In the present study we investigated the effects of panduratin A, isolated from 
Boesenbergia rotunda, on proliferation and apoptosis in A549 human non-small cell lung 
cancer cells. Cell proliferation and induction of apoptosis was determined by the real-time 
cellular analyzer (RTCA), MTT assay and High Content Screening (HCS). The RTCA 
assay indicated that panduratin A exhibited cytotoxicity, with an IC50 value of 4.4 µg/mL 
(10.8 µM). Panduratin A arrested cancer cells labeled with bromodeoxyuridine (BrdU) and 
phospho-Histone H3 in the mitotic phase. The cytotoxic effects of panduratin A were 
found to be accompanied by a dose-dependent induction of apoptosis, as assessed by DNA 
condensation, nuclear morphology and intensity, cell permeability, mitochondrial mass/ 
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potential, F-actin and cytochrome c. In addition, treatment with an apoptosis-inducing 
concentration of panduratin A resulted in significant inhibition of Nuclear Factor-kappa 
Beta (NF-κB) translocation from cytoplasm to nuclei activated by tumor necrosis factor-
alpha (TNF-α), as illustrated by the HCS assay. Our study provides evidence for cell 
growth inhibition and induction of apoptosis by panduratin A in the A549 cell line, 
suggesting its therapeutic potential as an NF-κB inhibitor. 
Keywords: Panduratin A, apoptosis, High Content Screening, Real-time Cellular 
Analyzer, NF-κB 
 
1. Introduction 
The rhizomes of Boesenbergia rotunda (fingerroot, Chinese ginger) have been used as a condiment 
and folk medicine for the treatment of various ailments, including colic disorders, fungal infections 
and muscular pains [1]. In vitro studies on the extracts of B. rotunda and their isolated compounds 
have shown some beneficial pharmacological activities. Panduratin A (CAS Registry Number: 89837-52-5; 
molecular weight for C26H30O4: 406.52; Figure 1), a cyclohexenyl chalcone derivative isolated from B. 
rotunda, showed strong antimutagen activity in the Ames test using Salmonella typhimurium TA98 [2]. 
Besides that Tuchinda et al. reported that panduratin A had significant antiinflammatory activity 
against 12-O-tetradecanoylphorbol 13-acetate (TPA)-induced ear edema in rats. Recently, Yun et al. 
reported that panduratin A inhibited the growth of HT-29 colon cancer cells and induced apoptosis [3]. 
Moreover, the same authors also reported that panduratin A induced apoptosis and cell cycle arrest in 
human PC3 prostate cancer cells and MCF-7 breast cancer cells [4]. However, to our knowledge no 
research had been done on A549 cells and the role of NF-kB in the cancer cell inhibition of panduratin A. 
Figure 1. Chemical structure of panduratin A. 
 
The majority of anticancer drugs presently used in clinical settings have been described to induce 
cell death by apoptosis [5]. Apoptosis has been the subject of intense study and was originally 
described by Kerr et al. [6] as cell death with certain morphological characteristics. However, besides 
the morphological criteria, subsequent studies have described important biochemical hallmarks of 
apoptosis. One of the most important groups of proteins involved in apoptosis is the nuclear  
factor-kappa B (NF-κB). NF-κB is a ubiquitous transcription factor which plays an important role in 
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many physiological processes, such as cell proliferation, cell death, inflammation and immune 
response [7]. Under resting conditions, NF-κB is present as an inactive heterotrimer which consists of 
p50, p65, and I kappa B alpha (IκBα) subunits in the cytoplasm. Following activation by numerous of 
stimuli, IκBα protein undergoes phosphorylation and degradation. Unbound p50-p65 heterodimer 
translocates to the nucleus, subsequently binds with specific DNA motif in the promoter regions of 
target genes and activates their transcription. Dysregulation of NF-κB is implicated in many types of 
human cancers [8]. Thus, the inhibition of this signaling pathway could be able to halt  
tumor development. 
Recently we isolated panduratin A from the methanolic extract of B. rotunda [2-3] and in the 
present study, we demonstrate antiproliferative and proapoptotic effect of this compound in human 
A549 non-small cell lung cancer cells and delineate the mechanism of this effect. 
2. Results and Discussion 
2.1. Results 
2.1.1. Panduratin A Isolation 
B. rotunda has been shown [2-3] to contain the compound panduratin A (Figure 1), which was 
eluted with approximately 90% acetonitrile/water containing 0.1% (v/v) FA. Isolated panduratin A was 
shown to have an accurate mass of 407.2215 [(+)-ESI HRMS [M+H]+, ∆0.5 ppm for C26H31O4].  
2.1.2. Real-Time Cell Proliferation Assays 
In order to observe the kinetics of drug interaction with target cells, A549 were seeded in an 16X  
E-plate™ and continuously monitored until the cells reached the log growth phase, at which point 
different concentrations of panduratin A were added to the cells at the indicated final concentrations. 
From Figure 2A, the compound, or medium only were added at the time recorded CI values reached 
one third of the maximum CI, approximately 18 hours after seeding, when cells were in early 
logarithmic growth phase. Changes in the CI values were recorded immediately with panduratin A 
treated A549 cells. 
As shown in Figure 2A, a large decrease in CI was observed, reaching zero approximately 2 hours 
after treatment in higher dose (25 and 12.5 µg/mL of panduratin A), when cells had detached from the 
microelectrode surface. Panduratin A at the highest concentration initially induces a cytotoxic effect 
which is mainly due to cell death. Remarkably, the cells recover from the initial cytotoxic effect of the 
drug and start to re-proliferate in Figure 2A (doses of 3.13 and 6.25 µg/mL). All control cells, treated 
with medium alone, showed nearly identical CI profiles until the end of data collection, indicating 
similar growth behavior. Different curves observed immediately after panduratin A addition may 
reflect receptor and compound transportation events and need to be further evaluated. The sigmoidal 
dose response curves of panduratin A tested in RTCA are shown in Figure 2B. All curves have an r2 
greater than or equal to 0.99. 
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Figure 2. (A) Dynamic monitoring of drug interaction with target cells using the RTCA. 
A549 cells were seeded in 16X E-plate device were continuously monitored up to  
100 hours at which point panduratin A were added at the indicated final concentrations. CI 
values were normalized to the time point of compound addition, indicated by the vertical 
black line. (B) IC50 value in RTCA system after 24, 48 and 72 hours treatment of 
panduratin A. 
 
 
2.1.3. MTT Assay 
The sigmoidal dose response curves of panduratin A in the end-point assays are shown in Figure 3. 
All curves have an r2 greater than or equal to 0.95. Cell viability was analyzed using the MTT assay, 
measuring metabolic activity. In cells with normal metabolism, a tetrazolium salt is converted to 
formazan, measurable by change in absorbance. In A549 cells treated with panduratin A, metabolic 
activity decreased 24 hours after treatment. Medium alone experiment showed no effect on A549 cell 
viability and metabolism. Table 1 summarizes the IC50 values from RTCA (real-time assay) and MTT 
(end-point assay). 
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Figure 3. Dose response curves (using GraphPad Prism) of panduratin A tested in the 
MTT assays at 24, 48 and 72 hours treatment.  
 
Table 1. IC50 values (µg/mL) at 24, 48 and 72 hours for panduratin A on A549 cells. 
Panduratin A 
            RTCA (µg/mL) MTT (µg/mL) 
IC50 SEM IC50 SEM 
24 hrs 4.4008 0.9782 4.4040 0.3460 
48 hrs 4.3647 0.0728 3.7930 0.0156 
72 hrs  5.5453 0.0066 4.4190 0.0062 
2.1.4. Cell Cycle Phases Determination 
From Figures 4 and 5, panduratin A treatment resulted in G2/M phase arrest in A549 cells. BrdU 
and hosphor-histone H3 stained nuclear DNA content to distinguish 2N (G1 phase) and 4N (G2/M 
phase). The apoptosis induced by panduratin A is presumably a consequence of G2/M, with cells 
mostly being stained with mitosis-specific hosphor-histone H3 rather than BrdU. 
Figure 4. A549 cells were treated with medium or 5 µg/mL of cisplatin, doxorubicin, 
paclitaxel and panduratin A. Activation or inhibition of BrdU and hosphor-histone H3 after 
drug treatment for 24 hours being calculated and analyzed.  
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Figure 5. Staining of BrdU and hosphor-Histone H3 in A549 cells. S-phase cells were 
detected with BrdU staining, and mitotic cells were stained with hosphor-Histone H3 
antibody. Cell images were acquired using the cellomics HCS Reader with a 10X objective 
lens.  
 
2.1.5. Cytotoxicity Assay 
This assay enables simultaneous measurement of several cell-health parameters: nuclear morphology, 
DNA content, cell membrane permeability and cytochrome c localization. Typical cytotoxic changes are 
illustrated in Figures 6 and 7. Panduratin A induced decreases in cell number (data not shown); nuclear 
area and mitochondrial membrane potential are readily visible, as are the increases in plasma membrane 
permeability. These effects occurred more rapidly, and followed a dose-response pattern. Cytotoxic 
effects were considered to occur only when the rate of change of fluorescence was unmistakably 
greater than for the negative controls. 
Figure 6. Representative images of A549 cells treated with medium alone and 5 µg/mL of 
panduratin A, all at 20X, and stained with Hoechst for nuclear, cell permeability dye, 
mitochondrial membrane potential dye and cytochrome c. The images from each row are 
obtained from the same field of the same treatment sample. A549 produced a marked 
reduction in nuclear area, mitochondrial membrane potential, and marked increases in 
membrane permeability. Circular outlines indicate the areas within cells in which 
fluorescence intensity is measured. 
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Figure 7. Changes in A) nuclear size and morphology, B) DNA content, C) cell 
permeability and D) cytochrome c localization were all measured simultaneously in A549 
cells. Following treatment with panduratin A, we saw statistically significant cell loss (data 
not shown), nuclear condensation, increased total nuclear intensity, increased cell 
permeability, and cytochrome c release from mitochondria with good p values. 
 
2.1.6. Apoptosis Determination 
To confirm the apoptosis induced by panduratin A, the changes in nuclear condensation, f-actin 
contents and mitochondrial mass/potential were determined simultaneously after treatment with 
different concentrations of panduratin A for 24 hours. Panduratin A induced dose-dependent increase 
of fluorescence intensity of nuclei (Figures 8 and 9A), f-actin content (Figures 8 and 9B) and 
mitochondrial mass/pontential (Figures 8 and 9C) of A549 cells. 
Image-based cell analysis can also provide information on cell density and thus give information 
about proliferation in the cell culture. The method described is not limited to studies of the three 
parameters presented here. By altering the selection of probes, we can study the activity of different 
enzymes or organelles [9]. Based on the parameter that been measured, we can define the stages of 
apoptosis (early, mid and late) upon treatment with 5 µg/mL of panduratin A. From Figure 9D, 70% of 
the A549 cells treated with panduratin A were at the mid stage of apoptosis. It would also be possible 
to extract information about the cell cycle phase for each cell based on the total intensity of the 
Hoechst 33342 or DAPI staining [10]. From Figure 9E, based on the DNA content in the cells after 
treatment with panduratin A, we can separate the <2N, 2N, 2N-4N, 4N and >4N of cell cycle phase. 
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Figure 8. Fluorescence photomicrographs of panduratin A-induced changes in apoptosis 
parameters acquired from the ArrayScan HCS Reader. Effects of incubation of A549 cells 
with panduratin A, compared to controls, respectively, on nuclear area, mitochondrial 
membrane potential and F-actin. Circular outlines indicate the areas within cells in which 
fluorescence intensity is measured. 
 
Figure 9. Quantitative analysis of panduratin A mediated. Dose-response histogram for 
each apoptosis parameter. Panduratin A increased the percentage of cells with condensed 
chromatin and F-action content in a concentration-dependent fashion at the same time 
caused loss of mitochondrial mass/potential. 
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2.1.7. NF-kB Activity 
In this study, we tested panduratin A for its in vitro inhibitory effects against NF-κB translocation 
activated by TNF-α and illustrated by HCS assay. Panduratin A exhibited significant inhibitory effects 
on the activation of NF-κB (Figure 10). In parallel, the morphological changes of NF-κB translocation 
indicated by immunofluorescence staining (Figure 11) showed an inhibitory effect of panduratin A on 
TNF-α-induced NF-κB translocation in a dose-dependent manner. In cells treated with control, most of 
the fluorescence staining for NF-κB are in the cytoplasm and rare NF-κB staining in nuclei area. When 
stimulating cells with the TNF-α alone, NF-κB staining significantly increased in nuclei area, 
suggesting that NF-κB translocated from cytoplasm into the nucleus. However, A549 cells were 
treated with 5 μg/mL of panduratin A, NF-κB translocation induced by TNF-α was inhibited. 
Figure 10. Dose-response histogram of panduration A treated A549 cells for 2 hours and 
then stimulated for 30 minutes with 10 ng/mL TNF-α for quantitative image analysis of 
intracellular targets.  
 
Figure 11. Stained A549 cells were treated with panduration A (5 µg/mL) for 2 hours and 
then stimulated for 30 minutes with 10 ng/mL TNF-α (NF-κB activation).  
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2.2. Discussions 
Several plant-derived bioactive agents have been shown to induce apoptosis in a number of 
experimental models of carcinogenesis [11]. Panduratin A had been shown to induce apoptosis in HT-29, 
CaP and DU145 [3]. In the present study, we investigated the anti-proliferative activity of panduratin A 
and the underlying mechanism in A549 cells with the current advanced technology of HCS and RTCA. 
In this study, panduratin A at higher concentration initially induces a cytotoxic effect which is 
mainly due to cell death. Remarkably, the cells recover from the initial cytotoxic effect of the drug and 
start to re-proliferate at 3.13 and 6.25 µg/mL after 40 hours of treatment. While it remains to be 
determined if this phenomenon is due to metabolism and inactivation of panduratin A or due to the 
emergence of a panduratin A-resistant subpopulation, this experiment clearly exemplifies the 
tremendous advantage of the real-time measurements offered by the RTCA system and allows us, the 
user, the opportunity to observe and assess the entire history of drug interaction with the target cells 
which provides further information in addition to cell viability or cytotoxicity. The phenomenon 
observed would have been easily missed by traditional single- or end-point assays such as MTT assay. 
On the hand, there was evidence that panduratin A treatment had no to little effect on normal human 
epithelial and fibroblast cells [4], hencer it’s suggested that panduratin A has selective cytotoxicity 
towards cancer cells. 
Induction of apoptosis and/or inhibition of cell proliferation are highly correlated with the activation 
of a variety of intracellular signaling pathways leading to arrest the cell cycle in the G1, S, or G2/M 
phase of the cell cycle [12]. Cell cycle regulation and its modulation by various plant-derived agents have 
gained widespread attention in recent years [13]. With paclitaxel, cells are only seen in G2/M-blocked [14]. 
The apoptotic pathway for paclitaxel has been directly examined [14]. Nocodazole, which induces M 
phase arrest, is frequently used for a G2/M checkpoint assay besides paclitaxel [15]. In the present 
study, apoptosis induced panduratin A is presumably a consequence of either G2/M block or the DNA 
damage due to abnormal mitotic arrest. We need to further investigate the effect of panduratin A on the 
expression of G2/M regulatory proteins like cdc family. 
Screening potential drugs for cytotoxicity is an essential aspect of the drug discovery process since 
cytotoxicity is a complex process affecting multiple parameters and pathways. After toxic insult, cells 
often undergo either apoptosis or necrosis. In this study, panduratin A treatment of A549 epithelial 
lung carcinoma cells led to a remarkable induction of apoptotic cells. Early during the initiation of 
apoptosis, cells lose contact with neighboring cells. Membranes and organelles including mitochondria 
are well preserved during early apoptotic cell death. Morphological hallmarks of apoptosis in the 
nucleus are chromatin condensation and nuclear fragmentation. Condensation and fragmentation of the 
nucleus can be seen. Panduratin A induced decreases in cell number, nuclear area, cell morphology, 
cell membrane permeability, cytochrome c localization and mitochondrial membrane potential are 
readily visible, as are the increases in DNA content and plasma membrane permeability. 
In addition to the nuclear fragmentation, the induction of cell death increases the F-actin content. 
Changes in the actin cytoskeleton have been reported as a potential parameter related to apoptotic 
changes [16]. However, this correlation is not observed in all cases. The actin cytoskeleton is known to 
be crucial in mediating cell responses to both internal and external signals. The exact role for actin in 
the panduratin A-induced cell death pathway remains unclear but there is now a significant amount of 
Molecules 2011, 16                            
 
 
2593
circumstantial evidence that indicates a role for actin in triggering cell death. Some of the clearest 
results supporting links between actin and apoptosis pathways in mammalian cells come from studies 
using drugs that affect actin turnover [16]. 
Besides that, a reduction in mitochondrial membrane potential could be seen after 24 hours of 
treatment with panduratin A. Mitochondria release apoptogenic factors through the outer membrane 
and dissipate the electrochemical gradient of the inner membrane. This is thought to occur via 
formation of the mitochondria permeability transition. Mitochondria have been described to play a key 
role and perhaps even a central role in the apoptotic process [17] due in part to the mitochondria being 
the ‘junction’ of at least two distinct signaling pathways. Hence, mitochondrial dysfunction has been 
shown to participate in the induction of apoptosis. In some apoptotic systems, loss of mitochondrial 
membrane potential (Δψm) may be an early event in the apoptotic process. However, there are 
emerging data suggesting that, depending on the model of apoptosis, the loss of Δψm may not be an 
early requirement for apoptosis, but on the contrary may be a consequence of the apoptotic-signaling 
pathway [17]. Mitochondrial control of apoptosis has been described at several levels: [6] maintenance 
of ATP production and [18] Δψm and mitochondrial membrane permeability for the release of certain 
apoptogenic factors from the intermembrane space into the cytosol [19]. Cytochrome c release has 
been suggested associated mitochondrial swelling and thus ruptures of the outer mitochondrial 
membrane [20]. Thus, in some systems, dissipation of Δψm has been associated with cytochrome c 
release from the mitochondria [21]. 
In this study, we tested panduratin A for its in vitro inhibitory effects against NF-κB translocation 
from cytoplasm to nucleus activated by TNF-α. Panduratin A exhibited significant inhibitory effects on 
the activation of NF-κB. This result provided a new evidence to support the suggestion that the 
apoptosis effect of panduratin A may occur through mechanisms of NF-κB inhibition. Aberrant 
regulation of NF-κB pathway has been shown in most of human cancers, including both solid tumors 
and hematological malignancies [22]. It has been shown that inhibition of the NF-κB signaling 
pathway could reduce cancer cells growth and induce apoptosis of cancer cells [23]. The activation of 
this signaling pathway could be able to promote tumor cells proliferation, angiogenesis, invasion, 
metastasis and block apoptosis [7]. Recently, NF-κB inhibitors have emerged as new therapeutic 
targets for cancer disease. Further studies should be carried out to investigate the mechanism of 
inhibitory action. 
Taken together, this study provided the first evidence that panduratin A inhibited A549 cell 
proliferation by apoptosis, which was associated with inhibition of translocation of NF-κB from 
cytoplasm to nucleus and G2/M phase arrest. These abilities of panduratin A to induce apoptosis and 
cell cycle arrest implies its potential as a chemotherapeutic agent or NF-κB inhibitor because many 
anticancer drugs are known to achieve their anticancer function by inducing apoptosis and cell cycle 
arrest in tumor cells. To the best of our knowledge, this was the first high content screening and real 
time viability assay conducted on panduratin A. Although the precise molecular mechanism by which 
apoptosis is induced by panduratin A remains unclear, it might be a potential anticancer agent against 
A549. 
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3. Experimental  
3.1. Materials 
All solvents (HPLC grade) were purchased from Fisher Scientific. A549 non-small cell lung cancer 
cell line was purchased from ATCC (Rockville, MD, USA). RPMI medium, penicillin, streptomycin 
solution and 0.25% trypsin solution were purchased from Invitrogen (Rockville, MD, USA). MTT, 
DMSO and heat-inactivated fetal bovine serum and paclitaxel were purchased from Sigma-Aldrich 
Chemicals (Saint Louis, MO, USA). Cell culture treated 96-well plates and cell culture flasks were 
purchased from Orange Scientific (Braine-l'Alleud, Belgium). 
3.2. Plant Materials and Extraction 
B. rotunda (4 g) and a voucher specimen with assession No. KU0098 is kept in the Phytochemistry 
Herbarium, University of Malaya. Dried plant materials were extracted twice with methanol (50 mL) 
for 48 hours at room temperature, replacing approximately the same volume of fresh methanol after 
the first 24 hours. The extracts were filtered through polyvinypyrrolidone to remove tannins before 
combining and drying in vacuo to obtain the crude extract (0.4 g). 
3.3. Fractionation and Preparation of Compounds 
The crude extract was first fractionated using reversed phase C18 analytical HPLC/LCMS-IT-TOF on a  
Shimadzu instrument equipped with a PDA detector and 80:20 splitting to a microtiter plate fraction 
collector (Gilson FC204). The column used was a Waters Xbridge RPC18 column (2.1 x 50 mm, particle 
size 2.5 μm), using acetonitrile and water as the mobile phase and a gradient of 10 to 100% (v/v) over  
7 minutes, flow rate of 0.5 mL/min and column temperature of 40 °C. Fractions were collected every 
0.5 minutes from run start until 9 minutes into a 96-well microtitre plate. The solvents were removed 
and the fractions were then re-dissolved in appropriate assay buffer to give a concentration equivalent 
to the IC50 concentration of the crude extract for cytotoxicity testing. 
Biological assay of the collected fractions located the cytotoxicity in the 6-7 mins region. This 
region contained a single major peak that was identified as panduratin A based on MS/MS data. 
Panduratin A was subsequently isolated from crude extract by preparative reversed-phase HPLC 
(Waters Nova-Pak C18 column, particle size 6 μm, 25 x 100 mm) using acetonitrile and water as 
eluents. A gradient of 60% to 100% (v/v) acetonitrile in water at a flow rate of 12 mL/min was applied 
over 50 minutes. Identity and purity (>98%) of the isolated panduratin A were determined by 
analytical HPLC and nuclear magnetic resonance (1H-NMR) spectroscopy. The 1H-NMR in CDCl3 
was found to be identical to that previously reported [24]. 
3.4. Cell Culture 
A549 cell line used in this study was maintained at 37 °C incubator with 5% CO2 saturation. Cells 
were cultured in RPMI media containing 10% FBS and 1% penicillin and streptomycin. 
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3.5. Real-Time Cell Proliferation Assays 
In vitro cell proliferation was assessed in xCELLigence Real-Time Cellular Analysis (RTCA) 
system (Roche, Germany). Briefly, background measurements were took after adding 50 µL of the 
appropriate medium to the wells of the 16X E-plate. Cell suspension (1.25 × 104 cells/well) was added 
to the wells. The attachment and proliferation of the cells were monitored every 5 minutes using 
RTCA system. Approximately 18 hours after seeding, when the cells in the log growth phase, the cells 
were treated with 100 µL of panduratin A in various concentrations (µg/mL) dissolved in cell culture 
media and continuously monitored for up to 72 hours. The cells were also treated with medium alone, 
which served as vehicle control. Cell sensor impedance was expressed as an arbitrary unit called the 
Cell Index. 
3.6. MTT Assay 
Assays were performed after 24, 48 and 72 hours treatment periods. 50 µL of MTT solution  
(2 mg/ml) was transferred to each well. Plates were incubated for 2 hours at 37 °C and discarded the 
supernatants. DMSO was added to ensure total solubility of formazan crystals and absorbance was 
recorded at 570 nm with Plate Chameleon V microplate reader (Hidex, Turku, Finland). The percent 
viability was expressed as absorbance in the presence of test compound as a percentage of that in the 
vehicle control. 
3.7. Cell Cycle Phases 
The Cellomics Cell Cycle Kit is for quantification of nuclear DNA content to distinguish DNA 
replication in S phase cells and mitosis marker in M phase cells. This kit allows direct measurements 
of bromodeoxyuridine (BrdU) incorporation and mitosis-specific histone H3 phosphorylation. The 
assay was performed according to manufacturer’s instructions. Plates were analyzed using the 
ArrayScan high content screening (HCS) system (Cellomics Inc., Pittsburgh, PA, USA). 
3.8. Multiparametric Cytotoxicity Assay 
Multiparametric Cytotoxicity HCS assays were used as described in detail previously by [25]. 
Plates were analyzed using the ArrayScan HCS system. 
3.9. Apoptosis Determination 
Multiparameter Apoptosis Kit provides quantitative analysis of apoptosis by analysis of nuclear 
morphology, mitochondrial mass/potential and F-actin content. Apoptosis HitKitTM reagents 
(Cellomics) was used according to the manufacturer’s instructions. Plate was evaluated on the 
ArrayScan HCS Reader and analyzed with Apoptosis BioApplication software. 
3.10. Detection of NF-kB Activity 
HCS was used to measure the inhibitory effects of panduratin A on TNF-α-induced NF-κB 
activation, i.e. nuclear translocation of NF-κB. The experiments were performed according to 
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manufacturer’s instructions for the NF-κB activation kit (Cellomics). ArrayScan reader was used to 
quantify the difference between the intensity of nuclear and cytoplasmic NF-κB-associated 
fluorescence, reported as translocation parameter. 
3.11. Image Acquisition and Cytometric Analysis 
Plates with stained cells were analyzed using the ArrayScan HCS system (Cellomics). This system 
is a computerized automated fluorescence imaging microscope that automatically identifies stained 
cells and reports the intensity and distribution of fluorescence in individual cells. The  
Array-Scan HCS system scans multiple fields in individual wells to acquire and analyze images of 
single cells according to defined algorithms. In each well, 1,000 cells were analyzed. Automatic 
focusing was performed in the nuclear channel to ensure focusing regardless of staining intensities in 
the other channels. Images were acquired for each fluorescence channel, using suitable filters. Images 
and data regarding intensity and texture of the fluorescence within each cell, as well as the average 
fluorescence of the cell population within the well were stored in a Microsoft SQL database for easy 
retrieval. Data were captured, extracted and analyzed with ArrayScan II Data Acquisition and Data 
Viewer version 3.0 (Cellomics). 
3.12. Statistical Analysis 
Each experiment was performed at least two times. Results are expressed as the means  
value ± standard deviation (SD). Statistical analysis was performed with one-way analysis of variance 
(ANOVA), with Dunnett's Multiple Comparison Test to identify between-group differences using 
GraphPad Prism software (version 4.0; GraphPad Software Inc., San Diego, CA). Statistical 
significance is expressed as ***, P < 0.001; **, P < 0.01; *, P < 0.05. Log IC50 calculations were 
performed using the built-in algorithms for dose-response curves with variable slope. A fixed 
maximum value of the dose-response curve was set to the maximum obtained value for each drug. 
4. Conclusions 
We have presented a real-time cytotoxicty mediated by panduratin A and a series of 
multiparametric HCS assays demonstrating multiple apoptotic parameters on A549 adherent cells. 
Panduratin A has benefits as a NF-κB inhibitor to inhibit the proliferation of cancer cells by blocking 
cells in G2/M phase and by inducing apoptosis. Further studies should be carried out to investigate the 
mechanism of inhibitory action, such as quantitative analysis of IκB kinase activity, IκB alpha 
phosphorylation and degradation, p50 and p65 nuclear translocation, DNA binding and  
NF-κB-dependent reporter gene expression. 
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